ON-DEMAND WEBINARS

Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.

CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.

Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.

Gain insight into how a patient-centric approach to supply chain innovation in early phase development can accelerate your advanced therapy clinical trial programs.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

Rachel-Home-Page

CATALENT CORNER

GettyImages-1333159166-cold-chain-shipping-logistics-transportation
Insights from Catalent's Clinical Supply Experts

SPONSORED CONTENT

Impact Of Supplier Choice On APAC Clinical Trial Execution

Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.

Watch the webinar >>